In the last 12 months, insiders at ANGIODYNAMICS INC ($ANGO) filed 184 transactions with the SEC: 8 open-market purchases totaling $442,380 and 2 sales totaling $109,976. Net insider sentiment: net buying.
ANGIODYNAMICS INC operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Clemmer James C (President and CEO) — 34 transactions totaling $1,282,282
- Trowbridge Stephen A (EVP and CFO) — 31 transactions totaling $248,327
- Helsel Dave (SVP Global Operations and R&D) — 14 transactions totaling $120,651
- Weiss Lawrence T (SVP, Chief Legal Officer) — 5 transactions totaling $118,100
- Piccinini Laura (SVP International) — 20 transactions totaling $111,868
View all SEC Filings for ANGIODYNAMICS INC (ANGO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 21, 2025 | Weiss Lawrence T | SVP, Chief Legal Officer | P | Common Stock | 10000 | $11.81 | 93,597.0000 | 41,607,877 | 11.96% | 0.02% |
| Oct. 13, 2025 | Trowbridge Stephen A | EVP and CFO | P | Common Stock | 890 | $11.16 | 256,629.0000 | 41,607,877 | 0.35% | 0.00% |
| Oct. 9, 2025 | Clemmer James C | President and CEO | P | Common Stock | 10000 | $11.15 | 882,529.0000 | 41,607,877 | 1.15% | 0.02% |
| July 20, 2025 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 359 | $8.69 | 92,692.0000 | 41,607,877 | 0.39% | 0.00% |
| July 21, 2025 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 395 | $8.99 | 92,297.0000 | 41,607,877 | 0.43% | 0.00% |
| July 20, 2025 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 717 | $8.69 | 256,406.0000 | 41,607,877 | 0.28% | 0.00% |
| July 20, 2025 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 251 | $8.69 | 70,180.0000 | 41,607,877 | 0.36% | 0.00% |
| July 19, 2025 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 2585 | $8.69 | 257,123.0000 | 41,607,877 | 1.00% | 0.01% |
| July 21, 2025 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 667 | $8.99 | 255,739.0000 | 41,607,877 | 0.26% | 0.00% |
| July 21, 2025 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 277 | $8.99 | 69,903.0000 | 41,607,877 | 0.39% | 0.00% |
| July 19, 2025 | Clemmer James C | President and CEO | F | Common Stock | 344 | $8.69 | 887,491.0000 | 41,607,877 | 0.04% | 0.00% |
| July 19, 2025 | Clemmer James C | President and CEO | F | Common Stock | 8307 | $8.69 | 879,184.0000 | 41,607,877 | 0.94% | 0.02% |
| July 20, 2025 | Clemmer James C | President and CEO | F | Common Stock | 2982 | $8.69 | 876,202.0000 | 41,607,877 | 0.34% | 0.01% |
| July 19, 2025 | Piccinini Laura | SVP International | F | Common Stock | 1983 | $8.69 | 67,372.0000 | 41,607,877 | 2.86% | 0.00% |
| July 20, 2025 | Piccinini Laura | SVP International | F | Common Stock | 616 | $8.69 | 66,756.0000 | 41,607,877 | 0.91% | 0.00% |
| July 19, 2025 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 735 | $8.69 | 70,431.0000 | 41,607,877 | 1.03% | 0.00% |
| July 20, 2025 | Clemmer James C | President and CEO | F | Common Stock | 3673 | $8.99 | 872,529.0000 | 41,607,877 | 0.42% | 0.01% |
| July 19, 2025 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 1025 | $8.69 | 93,051.0000 | 41,607,877 | 1.09% | 0.00% |
| July 17, 2025 | Piccinini Laura | SVP International | F | Common Stock | 3074 | $8.74 | 69,355.0000 | 41,607,877 | 4.24% | 0.01% |
| July 16, 2025 | Auen Eileen O'Shea | Not found | A | Common Stock | 17675 | $0.00 | 104,718.0000 | 41,607,877 | 20.31% | 0.04% |
| July 16, 2025 | Nighan Warren JR | SVP Quality and Regulatory | A | Common Stock | 29349 | $0.00 | 71,166.0000 | 41,607,877 | 70.18% | 0.07% |
| July 16, 2025 | Nighan Warren JR | SVP Quality and Regulatory | A | Performance Right | 29349 | $0.00 | 29,349.0000 | 41,607,877 | 9999.99% | 0.07% |
| July 16, 2025 | Clemmer James C | President and CEO | A | Common Stock | 206253 | $0.00 | 887,835.0000 | 41,607,877 | 30.26% | 0.50% |
| July 16, 2025 | Clemmer James C | President and CEO | A | Performance Right | 206253 | $0.00 | 206,253.0000 | 41,607,877 | 9999.99% | 0.50% |
| July 16, 2025 | Weiss Lawrence T | SVP, Chief Legal Officer | A | Common Stock | 30900 | $0.00 | 83,597.0000 | 41,607,877 | 58.64% | 0.07% |
| July 16, 2025 | Weiss Lawrence T | SVP, Chief Legal Officer | A | Performance Right | 30900 | $0.00 | 30,900.0000 | 41,607,877 | 9999.99% | 0.07% |
| July 16, 2025 | Trowbridge Stephen A | EVP and CFO | A | Common Stock | 86997 | $0.00 | 259,708.0000 | 41,607,877 | 50.37% | 0.21% |
| July 16, 2025 | Trowbridge Stephen A | EVP and CFO | A | Performance Right | 86997 | $0.00 | 86,997.0000 | 41,607,877 | 9999.99% | 0.21% |
| July 16, 2025 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Common Stock | 26268 | $0.00 | 94,076.0000 | 41,607,877 | 38.74% | 0.06% |
| July 16, 2025 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Performance Right | 26268 | $0.00 | 26,268.0000 | 41,607,877 | 9999.99% | 0.06% |
| July 16, 2025 | DONNELLY HOWARD W | Not found | A | Common Stock | 17675 | $0.00 | 167,051.0000 | 41,607,877 | 11.83% | 0.04% |
| July 16, 2025 | Piccinini Laura | SVP International | A | Common Stock | 32423 | $0.00 | 72,429.0000 | 41,607,877 | 81.05% | 0.08% |
| July 16, 2025 | Piccinini Laura | SVP International | A | Performance Right | 32423 | $0.00 | 32,423.0000 | 41,607,877 | 9999.99% | 0.08% |
| July 16, 2025 | Burgess Lorinda | Not found | A | Common Stock | 17675 | $0.00 | 55,257.0000 | 41,607,877 | 47.03% | 0.04% |
| July 16, 2025 | Tarnoff Michael E | Not found | A | Common Stock | 17675 | $0.00 | 83,378.0000 | 41,607,877 | 26.90% | 0.04% |
| July 16, 2025 | REED JAN STERN | Not found | A | Common Stock | 17675 | $0.00 | 105,034.0000 | 41,607,877 | 20.23% | 0.04% |
| July 16, 2025 | Licitra Karen A | Not found | A | Common Stock | 17675 | $0.00 | 90,435.0000 | 41,607,877 | 24.29% | 0.04% |
| July 16, 2025 | JOHNSON WESLEY | Not found | A | Common Stock | 17675 | $0.00 | 143,538.0000 | 41,607,877 | 14.04% | 0.04% |
| Jan. 16, 2025 | Nighan Warren JR | SVP Quality and Regulatory | S | Common Stock | 4060 | $12.31 | 41,817.0000 | 40,801,597 | 8.85% | 0.01% |
| Dec. 2, 2024 | Weiss Lawrence T | SVP, Chief Legal Officer | A | Non-Qualified Stock Option (right to buy) | 103650 | $0.00 | 103,650.0000 | 40,801,597 | 9999.99% | 0.25% |
| Dec. 2, 2024 | Weiss Lawrence T | SVP, Chief Legal Officer | A | Common Stock | 52697 | $0.00 | 52,697.0000 | 40,801,597 | 9999.99% | 0.13% |
| Oct. 10, 2024 | Nighan Warren JR | SVP Quality and Regulatory | P | Common Stock | 100 | $6.08 | 45,877.0000 | 40,801,597 | 0.22% | 0.00% |
| Oct. 7, 2024 | Nighan Warren JR | SVP Quality and Regulatory | P | Common Stock | 768 | $6.09 | 45,777.0000 | 40,801,597 | 1.71% | 0.00% |
| Oct. 8, 2024 | Trowbridge Stephen A | EVP and CFO | P | Common Stock | 1700 | $5.86 | 172,711.0000 | 40,801,597 | 0.99% | 0.00% |
| Oct. 7, 2024 | Clemmer James C | President and CEO | P | Common Stock | 20000 | $6.03 | 681,582.0000 | 40,801,597 | 3.02% | 0.05% |
| July 17, 2024 | Clemmer James C | President and CEO | M | Common Stock | 56279 | $0.00 | 690,312.0000 | 40,801,597 | 8.88% | 0.14% |
| July 17, 2024 | Clemmer James C | President and CEO | F | Common Stock | 28730 | $7.40 | 661,582.0000 | 40,801,597 | 4.16% | 0.07% |
| July 17, 2024 | Clemmer James C | President and CEO | M | Performance Right | 52378 | $0.00 | 0.0000 | 40,801,597 | 0.00% | 0.13% |
| July 17, 2024 | Nighan Warren JR | SVP Quality and Regulatory | M | Common Stock | 5677 | $0.00 | 46,675.0000 | 40,801,597 | 13.85% | 0.01% |
| July 17, 2024 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 1666 | $7.40 | 45,009.0000 | 40,801,597 | 3.57% | 0.00% |
| July 17, 2024 | Nighan Warren JR | SVP Quality and Regulatory | M | Performance Right | 7550 | $0.00 | 0.0000 | 40,801,597 | 0.00% | 0.02% |
| July 17, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | M | Common Stock | 6600 | $0.00 | 70,187.0000 | 40,801,597 | 10.38% | 0.02% |
| July 17, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 2379 | $7.40 | 67,808.0000 | 40,801,597 | 3.39% | 0.01% |
| July 17, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | M | Performance Right | 8777 | $0.00 | 0.0000 | 40,801,597 | 0.00% | 0.02% |
| July 17, 2024 | Trowbridge Stephen A | EVP and CFO | M | Common Stock | 11142 | $0.00 | 177,612.0000 | 40,801,597 | 6.69% | 0.03% |
| July 17, 2024 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 4016 | $7.40 | 173,596.0000 | 40,801,597 | 2.26% | 0.01% |
| July 19, 2024 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 2585 | $7.18 | 171,011.0000 | 40,801,597 | 1.49% | 0.01% |
| July 17, 2024 | Trowbridge Stephen A | EVP and CFO | M | Performance Right | 14817 | $0.00 | 0.0000 | 40,801,597 | 0.00% | 0.04% |
| July 17, 2024 | Piccinini Laura | SVP International | F | Common Stock | 2485 | $7.40 | 40,006.0000 | 40,801,597 | 5.85% | 0.01% |
| July 17, 2024 | Piccinini Laura | SVP International | M | Performance Right | 5903 | $0.00 | 0.0000 | 40,801,597 | 0.00% | 0.01% |
| July 17, 2024 | Piccinini Laura | SVP International | M | Common Stock | 4439 | $0.00 | 42,491.0000 | 40,801,597 | 11.67% | 0.01% |
| July 21, 2024 | Piccinini Laura | SVP International | F | Common Stock | 413 | $7.13 | 38,052.0000 | 40,801,597 | 1.07% | 0.00% |
| July 20, 2024 | Clemmer James C | President and CEO | F | Common Stock | 2982 | $7.13 | 637,405.0000 | 40,801,597 | 0.47% | 0.01% |
| July 21, 2024 | Clemmer James C | President and CEO | F | Common Stock | 3372 | $7.13 | 634,033.0000 | 40,801,597 | 0.53% | 0.01% |
| July 20, 2024 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 251 | $7.13 | 41,275.0000 | 40,801,597 | 0.60% | 0.00% |
| July 21, 2024 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 277 | $7.13 | 40,998.0000 | 40,801,597 | 0.67% | 0.00% |
| July 20, 2024 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 717 | $7.13 | 167,137.0000 | 40,801,597 | 0.43% | 0.00% |
| July 21, 2024 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 667 | $7.13 | 166,470.0000 | 40,801,597 | 0.40% | 0.00% |
| July 20, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 359 | $7.13 | 63,982.0000 | 40,801,597 | 0.56% | 0.00% |
| July 21, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 395 | $7.13 | 63,587.0000 | 40,801,597 | 0.62% | 0.00% |
| July 20, 2024 | Piccinini Laura | SVP International | F | Common Stock | 616 | $7.13 | 38,465.0000 | 40,801,597 | 1.58% | 0.00% |
| July 19, 2024 | Piccinini Laura | SVP International | F | Common Stock | 1983 | $7.18 | 39,081.0000 | 40,801,597 | 4.83% | 0.00% |
| July 19, 2024 | Nighan Warren JR | SVP Quality and Regulatory | F | Common Stock | 735 | $7.18 | 41,526.0000 | 40,801,597 | 1.74% | 0.00% |
| July 19, 2024 | Clemmer James C | President and CEO | F | Common Stock | 8307 | $7.18 | 636,570.0000 | 40,801,597 | 1.29% | 0.02% |
| July 19, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 1025 | $7.18 | 64,341.0000 | 40,801,597 | 1.57% | 0.00% |
| July 19, 2024 | Clemmer James C | President and CEO | A | Common Stock | 3817 | $0.00 | 640,387.0000 | 40,801,597 | 0.60% | 0.01% |
| July 19, 2024 | Clemmer James C | President and CEO | A | Performance Right | 7633 | $0.00 | 7,633.0000 | 40,801,597 | 9999.99% | 0.02% |
| July 19, 2024 | Clemmer James C | President and CEO | A | Non-Qualified Stock Option (right to buy) | 7466 | $0.00 | 7,466.0000 | 40,801,597 | 9999.99% | 0.02% |
| July 17, 2024 | Trowbridge Stephen A | EVP and CFO | A | Common Stock | 38953 | $0.00 | 167,854.0000 | 40,801,597 | 30.22% | 0.10% |
| July 17, 2024 | Piccinini Laura | SVP International | A | Common Stock | 21971 | $0.00 | 41,064.0000 | 40,801,597 | 115.07% | 0.05% |
| July 17, 2024 | Piccinini Laura | SVP International | A | Performance Right | 30428 | $0.00 | 30,428.0000 | 40,801,597 | 9999.99% | 0.07% |
| July 17, 2024 | Piccinini Laura | SVP International | A | Non-Qualified Stock Option (right to buy) | 29863 | $0.00 | 29,863.0000 | 40,801,597 | 9999.99% | 0.07% |
| July 17, 2024 | Nighan Warren JR | SVP Quality and Regulatory | A | Common Stock | 18733 | $0.00 | 42,261.0000 | 40,801,597 | 79.62% | 0.05% |
| July 17, 2024 | Nighan Warren JR | SVP Quality and Regulatory | A | Performance Right | 23952 | $0.00 | 23,952.0000 | 40,801,597 | 9999.99% | 0.06% |
| July 17, 2024 | Nighan Warren JR | SVP Quality and Regulatory | A | Non-Qualified Stock Option (right to buy) | 23507 | $0.00 | 23,507.0000 | 40,801,597 | 9999.99% | 0.06% |
| July 17, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Common Stock | 12350 | $0.00 | 65,366.0000 | 40,801,597 | 23.29% | 0.03% |
| July 17, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Performance Right | 24699 | $0.00 | 24,699.0000 | 40,801,597 | 9999.99% | 0.06% |
| July 17, 2024 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Non-Qualified Stock Option (right to buy) | 24240 | $0.00 | 24,240.0000 | 40,801,597 | 9999.99% | 0.06% |
| July 17, 2024 | REED JAN STERN | Not found | A | Common Stock | 20541 | $0.00 | 87,359.0000 | 40,801,597 | 30.74% | 0.05% |
| July 17, 2024 | Tarnoff Michael E | Not found | A | Common Stock | 20541 | $0.00 | 65,703.0000 | 40,801,597 | 45.48% | 0.05% |
| July 17, 2024 | JOHNSON WESLEY | Not found | A | Common Stock | 20541 | $0.00 | 125,863.0000 | 40,801,597 | 19.50% | 0.05% |
| July 17, 2024 | Clemmer James C | President and CEO | A | Common Stock | 105811 | $0.00 | 644,877.0000 | 40,801,597 | 19.63% | 0.26% |
| July 17, 2024 | Clemmer James C | President and CEO | A | Performance Right | 211622 | $0.00 | 211,622.0000 | 40,801,597 | 9999.99% | 0.52% |
| July 19, 2023 | Clemmer James C | President and CEO | A | Non-Qualified Stock Option (right to buy) | 207693 | $0.00 | 207,693.0000 | 39,981,422 | 9999.99% | 0.52% |
| July 17, 2024 | DONNELLY HOWARD W | Not found | A | Common Stock | 20541 | $0.00 | 149,376.0000 | 40,801,597 | 15.94% | 0.05% |
| July 17, 2024 | Burgess Lorinda | Not found | A | Common Stock | 20541 | $0.00 | 37,582.0000 | 40,801,597 | 120.54% | 0.05% |
| July 17, 2024 | Trowbridge Stephen A | EVP and CFO | A | Performance Right | 77905 | $0.00 | 77,905.0000 | 40,801,597 | 9999.99% | 0.19% |
| July 17, 2024 | Trowbridge Stephen A | EVP and CFO | A | Non-Qualified Stock Option (right to buy) | 76458 | $0.00 | 76,458.0000 | 40,801,597 | 9999.99% | 0.19% |
| July 17, 2024 | Licitra Karen A | Not found | A | Common Stock | 20541 | $0.00 | 72,760.0000 | 40,801,597 | 39.34% | 0.05% |
| July 17, 2024 | Auen Eileen O'Shea | Not found | A | Common Stock | 20541 | $0.00 | 87,043.0000 | 40,801,597 | 30.89% | 0.05% |
| April 8, 2024 | Clemmer James C | President and CEO | P | Common Stock | 10000 | $6.70 | 539,066.0000 | 39,981,422 | 1.89% | 0.03% |
| Feb. 29, 2024 | Trowbridge Stephen A | EVP and CFO | A | Common Stock | 1927 | $4.67 | 128,901.0000 | 39,981,422 | 1.52% | 0.00% |
| July 19, 2023 | Clemmer James C | President and CEO | M | Common Stock | 69676 | $0.00 | 598,742.0000 | 39,981,422 | 13.17% | 0.17% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | M | Performance Right | 13453 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.03% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 3103 | $8.92 | 53,016.0000 | 39,981,422 | 5.53% | 0.01% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | M | Common Stock | 8610 | $0.00 | 56,119.0000 | 39,981,422 | 18.12% | 0.02% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | M | Performance Right | 11782 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.03% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | F | Common Stock | 2716 | $8.92 | 62,951.0000 | 39,981,422 | 4.14% | 0.01% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | M | Common Stock | 7539 | $0.00 | 65,667.0000 | 39,981,422 | 12.97% | 0.02% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | M | Performance Right | 15081 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.04% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | F | Common Stock | 3477 | $8.92 | 34,462.0000 | 39,981,422 | 9.16% | 0.01% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | M | Common Stock | 9650 | $0.00 | 37,939.0000 | 39,981,422 | 34.11% | 0.02% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 6975 | $8.92 | 126,974.0000 | 39,981,422 | 5.21% | 0.02% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | M | Performance Right | 30242 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.08% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | M | Common Stock | 19354 | $0.00 | 133,949.0000 | 39,981,422 | 16.89% | 0.05% |
| July 19, 2023 | Clemmer James C | President and CEO | M | Performance Right | 108871 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.27% |
| July 19, 2023 | Clemmer James C | President and CEO | F | Common Stock | 34296 | $8.92 | 564,446.0000 | 39,981,422 | 5.73% | 0.09% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | M | Performance Right | 30242 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.08% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 3159 | $8.92 | 120,205.0000 | 39,981,422 | 2.56% | 0.01% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | M | Common Stock | 8769 | $0.00 | 123,364.0000 | 39,981,422 | 7.65% | 0.02% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | M | Performance Right | 11782 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.03% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | F | Common Stock | 1230 | $8.92 | 60,313.0000 | 39,981,422 | 2.00% | 0.00% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | M | Common Stock | 3415 | $0.00 | 61,543.0000 | 39,981,422 | 5.87% | 0.01% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | M | Performance Right | 13453 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.03% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 1404 | $8.92 | 50,005.0000 | 39,981,422 | 2.73% | 0.00% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | M | Common Stock | 3900 | $0.00 | 51,409.0000 | 39,981,422 | 8.21% | 0.01% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | M | Performance Right | 15081 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.04% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | F | Common Stock | 1575 | $8.92 | 31,085.0000 | 39,981,422 | 4.82% | 0.00% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | M | Common Stock | 4371 | $0.00 | 32,660.0000 | 39,981,422 | 15.45% | 0.01% |
| July 19, 2023 | Clemmer James C | President and CEO | M | Performance Right | 108871 | $0.00 | 0.0000 | 39,981,422 | 100.00% | 0.27% |
| July 19, 2023 | Clemmer James C | President and CEO | F | Common Stock | 11379 | $8.92 | 549,259.0000 | 39,981,422 | 2.03% | 0.03% |
| July 19, 2023 | Clemmer James C | President and CEO | M | Common Stock | 31572 | $0.00 | 560,638.0000 | 39,981,422 | 5.97% | 0.08% |
| July 21, 2023 | Helsel Dave | SVP Global Operations and R&D | F | Common Stock | 365 | $8.65 | 28,289.0000 | 39,981,422 | 1.27% | 0.00% |
| July 20, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 717 | $8.74 | 115,262.0000 | 39,981,422 | 0.62% | 0.00% |
| July 21, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 667 | $8.65 | 114,595.0000 | 39,981,422 | 0.58% | 0.00% |
| July 20, 2023 | Clemmer James C | President and CEO | F | Common Stock | 2982 | $8.74 | 532,438.0000 | 39,981,422 | 0.56% | 0.01% |
| July 21, 2023 | Clemmer James C | President and CEO | F | Common Stock | 3372 | $8.65 | 529,066.0000 | 39,981,422 | 0.63% | 0.01% |
| July 20, 2023 | Helsel Dave | SVP Global Operations and R&D | F | Common Stock | 332 | $8.74 | 28,654.0000 | 39,981,422 | 1.15% | 0.00% |
| July 20, 2023 | Centea Scott | SVP/GM, VIT | F | Common Stock | 333 | $8.74 | 58,383.0000 | 39,981,422 | 0.57% | 0.00% |
| July 21, 2023 | Centea Scott | SVP/GM, VIT | F | Common Stock | 255 | $8.65 | 58,128.0000 | 39,981,422 | 0.44% | 0.00% |
| July 20, 2023 | Piccinini Laura | SVP International | F | Common Stock | 616 | $8.74 | 19,506.0000 | 39,981,422 | 3.06% | 0.00% |
| July 21, 2023 | Piccinini Laura | SVP International | F | Common Stock | 413 | $8.65 | 19,093.0000 | 39,981,422 | 2.12% | 0.00% |
| July 20, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 359 | $8.74 | 47,904.0000 | 39,981,422 | 0.74% | 0.00% |
| July 21, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 395 | $8.65 | 47,509.0000 | 39,981,422 | 0.82% | 0.00% |
| July 19, 2023 | Piccinini Laura | SVP International | A | Common Stock | 14168 | $0.00 | 20,122.0000 | 39,981,422 | 237.96% | 0.04% |
| July 19, 2023 | Clemmer James C | President and CEO | A | Non-Qualified Stock Option (right to buy) | 190778 | $0.00 | 190,778.0000 | 39,981,422 | 9999.99% | 0.48% |
| July 19, 2023 | Clemmer James C | President and CEO | A | Performance Right | 184361 | $0.00 | 184,361.0000 | 39,981,422 | 9999.99% | 0.46% |
| July 19, 2023 | Clemmer James C | President and CEO | A | Common Stock | 92181 | $0.00 | 535,420.0000 | 39,981,422 | 20.80% | 0.23% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | A | Non-Qualified Stock Option (right to buy) | 21913 | $0.00 | 21,913.0000 | 39,981,422 | 9999.99% | 0.05% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | A | Performance Right | 21176 | $0.00 | 21,176.0000 | 39,981,422 | 9999.99% | 0.05% |
| July 19, 2023 | Centea Scott | SVP/GM, VIT | A | Common Stock | 10588 | $0.00 | 58,716.0000 | 39,981,422 | 22.00% | 0.03% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | A | Non-Qualified Stock Option (right to buy) | 22329 | $0.00 | 22,329.0000 | 39,981,422 | 9999.99% | 0.06% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | A | Performance Right | 21578 | $0.00 | 21,578.0000 | 39,981,422 | 9999.99% | 0.05% |
| July 19, 2023 | Helsel Dave | SVP Global Operations and R&D | A | Common Stock | 10789 | $0.00 | 28,986.0000 | 39,981,422 | 59.29% | 0.03% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | A | Non-Qualified Stock Option (right to buy) | 59378 | $0.00 | 59,378.0000 | 39,981,422 | 9999.99% | 0.15% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | A | Performance Right | 57381 | $0.00 | 57,381.0000 | 39,981,422 | 9999.99% | 0.14% |
| July 19, 2023 | Trowbridge Stephen A | EVP and CFO | A | Common Stock | 28691 | $0.00 | 115,979.0000 | 39,981,422 | 32.87% | 0.07% |
| July 19, 2023 | Piccinini Laura | SVP International | A | Non-Qualified Stock Option (right to buy) | 29322 | $0.00 | 29,322.0000 | 39,981,422 | 9999.99% | 0.07% |
| July 19, 2023 | Piccinini Laura | SVP International | A | Performance Right | 28336 | $0.00 | 28,336.0000 | 39,981,422 | 9999.99% | 0.07% |
| July 19, 2023 | Burgess Lorinda | Not found | A | Common Stock | 17041 | $0.00 | 17,041.0000 | 39,981,422 | 9999.99% | 0.04% |
| July 19, 2023 | Licitra Karen A | Not found | A | Common Stock | 17041 | $0.00 | 52,219.0000 | 39,981,422 | 48.44% | 0.04% |
| July 19, 2023 | Tarnoff Michael E | Not found | A | Common Stock | 17041 | $0.00 | 45,162.0000 | 39,981,422 | 60.60% | 0.04% |
| July 19, 2023 | Auen Eileen O'Shea | Not found | A | Common Stock | 17041 | $0.00 | 66,502.0000 | 39,981,422 | 34.45% | 0.04% |
| July 19, 2023 | REED JAN STERN | Not found | A | Common Stock | 17041 | $0.00 | 66,818.0000 | 39,981,422 | 34.23% | 0.04% |
| July 19, 2023 | DONNELLY HOWARD W | Not found | A | Common Stock | 17041 | $0.00 | 128,835.0000 | 39,981,422 | 15.24% | 0.04% |
| July 19, 2023 | JOHNSON WESLEY | Not found | A | Common Stock | 17041 | $0.00 | 105,322.0000 | 39,981,422 | 19.30% | 0.04% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Non-Qualified Stock Option (right to buy) | 23561 | $0.00 | 23,561.0000 | 39,981,422 | 9999.99% | 0.06% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Performance Right | 22768 | $0.00 | 22,768.0000 | 39,981,422 | 9999.99% | 0.06% |
| July 19, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | A | Common Stock | 11384 | $0.00 | 48,263.0000 | 39,981,422 | 30.87% | 0.03% |
| July 19, 2023 | Meteny Dennis S | Not found | A | Common Stock | 17041 | $0.00 | 140,019.0000 | 39,981,422 | 13.86% | 0.04% |
| July 17, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 376 | $9.56 | 87,288.0000 | 39,981,422 | 0.43% | 0.00% |
| July 17, 2023 | Clemmer James C | President and CEO | F | Common Stock | 2262 | $9.56 | 443,239.0000 | 39,981,422 | 0.51% | 0.01% |
| July 14, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 596 | $9.63 | 37,158.0000 | 39,981,422 | 1.58% | 0.00% |
| July 17, 2023 | Campbell Chad Thomas | SVP/GM, Vascular Access | F | Common Stock | 279 | $9.56 | 36,879.0000 | 39,981,422 | 0.75% | 0.00% |
| July 14, 2023 | Centea Scott | SVP/GM, VIT | F | Common Stock | 517 | $9.63 | 48,479.0000 | 39,981,422 | 1.06% | 0.00% |
| July 17, 2023 | Centea Scott | SVP/GM, VIT | F | Common Stock | 351 | $9.56 | 48,128.0000 | 39,981,422 | 0.72% | 0.00% |
| July 14, 2023 | Helsel Dave | SVP Global Operations and R&D | F | Common Stock | 679 | $9.63 | 18,510.0000 | 39,981,422 | 3.54% | 0.00% |
| July 17, 2023 | Helsel Dave | SVP Global Operations and R&D | F | Common Stock | 313 | $9.56 | 18,197.0000 | 39,981,422 | 1.69% | 0.00% |
| July 14, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 1362 | $9.63 | 87,664.0000 | 39,981,422 | 1.53% | 0.00% |
| July 14, 2023 | Clemmer James C | President and CEO | F | Common Stock | 4906 | $9.63 | 445,501.0000 | 39,981,422 | 1.09% | 0.01% |
| June 1, 2023 | Piccinini Laura | SVP International | F | Common Stock | 1400 | $9.64 | 5,954.0000 | 39,981,422 | 19.04% | 0.00% |
| Feb. 1, 2023 | ROSENZWEIG RICHARD C | SVP and General Counsel | F | Common Stock | 1137 | $13.36 | 15,730.0000 | 39,541,173 | 6.74% | 0.00% |
| Feb. 3, 2023 | Trowbridge Stephen A | EVP and CFO | F | Common Stock | 555 | $13.43 | 89,026.0000 | 39,541,173 | 0.62% | 0.00% |
| Jan. 31, 2023 | Helsel Dave | SVP Global Operations and R&D | S | Common Stock | 4633 | $12.95 | 19,189.0000 | 39,541,173 | 19.45% | 0.01% |